0001666690-18-000003.txt : 20180212 0001666690-18-000003.hdr.sgml : 20180212 20180212131903 ACCESSION NUMBER: 0001666690-18-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180212 DATE AS OF CHANGE: 20180212 EFFECTIVENESS DATE: 20180212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IB Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001666690 IRS NUMBER: 462638163 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-305380 FILM NUMBER: 18595409 BUSINESS ADDRESS: STREET 1: 8480 HONEYCUTT ROAD STREET 2: SUITE 120 CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 919-275-1933 MAIL ADDRESS: STREET 1: 8480 HONEYCUTT ROAD STREET 2: SUITE 120 CITY: RALEIGH STATE: NC ZIP: 27615 FORMER COMPANY: FORMER CONFORMED NAME: Innovate Biopharmaceuticals Inc. DATE OF NAME CHANGE: 20160211 D 1 primary_doc.xml X0708 D LIVE 0001666690 IB Pharmaceuticals Inc. 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC NORTH CAROLINA 27615 919-275-1933 DELAWARE Innovate Biopharmaceuticals Inc. Corporation true 2014 Jay Madan c/o IB Pharmaceuticals Inc. 8480 Honeycutt Road, Suite 120 Raleigh NC NORTH CAROLINA 27615 Executive Officer Director Sandeep Laumas c/o IB Pharmaceuticals Inc. 8480 Honeycutt Road, Suite 120 Raleigh NY NEW YORK 27615 Executive Officer Director Christopher Prior c/o IB Pharmaceuticals Inc. 8480 Honeycutt Road, Suite 120 Raleigh NC NORTH CAROLINA 27615 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2018-01-29 false true false 0 4800000 4800000 0 false 1 0 0 0 false IB Pharmaceuticals Inc. /s/ Jay Madan Jay Madan President 2018-02-12